1. |
Roblot F, Godet C, Le Moal G, et al. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis, 2002, 21(7): 523-531.
|
2. |
Travis WD, Costabel U, Hansell DM, et al. An Official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med, 2013, 188(6): 733-748.
|
3. |
Vidal S, Horra C, Martín J, et al. Pneumocystis jirovecii colonisation in patients with interstitial lung disease. Clin Microbiol Infect, 2006, 12(3): 231-235.
|
4. |
中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016年版). 中华结核和呼吸杂志, 2016, 39(4): 253-279.
|
5. |
Nevez G, Hauser PM, Le Gal S. Pneumocystis jirovecii. Trends Microbiol, 2020, 28(12): 1034-1035.
|
6. |
Gingerich AD, Norris KA, Mousa JJ. Pneumocystis pneumonia: immunity, vaccines, and treatments. Pathogens, 2021, 10(2): 236.
|
7. |
Amundson, WH, Racila E, Allen T, et al. Acute exacerbation of interstitial lung disease after procedures. Respir Med, 2019, 150: 30-37.
|
8. |
Collard HR, Ryerson CJ, Corte TJ, et al. Acute exacerbation of idiopathic pulmonary fibrosis. An International Working Group Report. Am J Respir Crit Care Med, 2016, 194(3): 265-275.
|
9. |
黄絮, 翁莉, 易丽, 等. 非HIV免疫抑制患者肺孢子菌肺炎合并急性呼吸衰竭的临床特征. 中华医学杂志, 2016, 96(38): 3057-3061.
|
10. |
Ghembaza A, Vautier M, Cacoub P, et al. Risk factors and prevention of pneumocystis jirovecii pneumonia in patients with autoimmune and inflammatory diseases. Chest, 2020, 158(6): 2323-2332.
|
11. |
Cillóniz C, Dominedò C, Álvarez-Martínez MJ, et al. Pneumocystis pneumonia in the twenty-first century: HIV-infected versus HIV-uninfected patients. Expert Rev Anti Infect Ther, 2019, 17(10): 787-801.
|
12. |
Enomoto T, Azuma A, Kohno A, et al. Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection. Respirology, 2010, 15(1): 126-131.
|
13. |
Li Y, Ghannoum M, Deng C, et al. Pneumocystis pneumonia in patients with inflammatory or autoimmune diseases: Usefulness of lymphocyte subtyping. Int J Infect Dis, 2017, 57: 108-115.
|
14. |
Theel ES, Jespersen DJ, Iqbal S, et al. Detection of (1, 3)-b-D-glucan in bronchoalveolar lavage and serum samples collected from immunocompromised hosts. Mycopathologia, 2013, 175(1-2): 33-41.
|
15. |
Tasaka S. Recent advances in the diagnosis and management of pneumocystis pneumonia. Tuberc Respir Dis, 2020, 83(2): 132.
|
16. |
Bateman M, Oladele R, Kolls JK. Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches. Med Mycol, 2020, 58(8): 1015-1028.
|
17. |
Halsema C, Johnson L, Baxter J. Diagnosis of Pneumocystis jirovecii pneumonia by detection of DNA in blood and oropharyngeal wash, compared with sputum. AIDS Res Hum Retroviruses, 2016, 32(5): 463-466.
|
18. |
Wieruszewski PM, Barreto JN, Frazee E, et al. Early corticosteroids for pneumocystis pneumonia in adults without HIV are not associated with better outcome. Chest, 2018, 154(3): 636-644.
|
19. |
Gharamti AA, Mundo W, Chastain DB, et al. Pneumocystis jirovecii pneumonia: a proposed novel model of corticosteroid benefit. Ther Adv Infect Dis, 2021, 8: 1-5.
|
20. |
Mundo W, Morales-Shnaider L, Tewahade S, et al. Lower mortality associated with adjuvant corticosteroid therapy in non-HIV-infected patients with Pneumocystis jirovecii pneumonia: a single-institution retrospective US cohort study. Open Forum Infect Dis, 2020, 7(9): ofaa354.
|
21. |
Ding L, Huang H, Wang H, el al. Adjunctive corticosteroids may be associated with better outcome for non-HIV Pneumocystis pneumonia with respiratory failure: a systemic review and meta-analysis of observational studies. Ann Intensive Care, 2020, 10(1): 34.
|
22. |
Azadeh N, Moua T, Baqir M, et al. Treatment of acute exacerbations of interstitial lung disease. Expert Rev Respir Med, 2018, 12(4): 309-313.
|
23. |
Marchioni A, Tonelli R, Ball L, et al. Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?. Crit Care, 2018, 22(1): 80.
|
24. |
Festic E, Gajic O, Limper AH, et al. Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection. Chest, 2005, 128(2): 573-579.
|
25. |
Rivera JGM, Ciofoaia GA. Pneumocystis jirovecii prophylaxis. Treasure Island (FL): StatPearls Publishing, 2022.
|
26. |
Stern A, Green H, Paul M, et al. Prophylaxis for pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev, 2014, (10): CD005590.
|